Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to February 2026, from the company's annual filing with the SEC.
| Salesyearly sales | $83.2B |
| Sales growthchange from the year before | +3.5% |
| Gross marginshare of sales left after the direct cost of what it sells | 27.2% |
| Operating marginshare of sales left after running the business | 0.9% |
| Net marginshare of sales kept as profit | 0.3% |
| Return on invested capitalprofit made on each $100 put into the business | 23.0% |
| Return on equityprofit vs. shareholders' accounting value | 8.7% |
| Interest coverhow many times profit covers interest payments | 1.6x |
| Change in share countnegative = the company is buying back its shares | -6.3% |
3 insiders bought $2.5M on the open market.
| Mccollam SharonPresident & CFO | BoughtJul 31 | 9,000 shat $11.48 · $103K |
| Morris SusanChief Executive Officer · Director | BoughtJul 28 | 39,409 shat $11.42 · $450K |
| Moriarty Thomas MEVP, M&A and Corporate Affairs | BoughtJul 27 | 170,500 shat $11.51 · $2.0M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy